title: Nerve growth factor rescues diabetic mice heart after ischemia/reperfusion injury via up-regulation of the TRPV1 receptor.
abstract: OBJECTIVE
  Nerve growth factor (NGF), a member of the neurotrophin family, plays an essential role in diabetic neuropathy and ischemic heart disease. In the present study, we explored the potential role of NGF and the involvement of TRPV1 receptor in isolated diabetic mouse hearts following ischemia/reperfusion (I/R) injury.
  
  
  METHODS
  Adenovirus-mediated NGF gene delivery was performed on diabetic and sham hearts 8weeks after streptozotocin treatment. The sciatic nerve conduction velocity was recorded using a biological signal acquisition system. Forty-eight hours after heart surgery, mice were subjected to I/R injury using a Langendorff system. Several cardiac parameters and the expression of associated molecules were analyzed during the experiment.
  
  
  RESULTS
  The sciatic nerve conduction velocity was reduced in diabetic mice compared with that in control mice. Decreased expression of NGF, TRPV1, and the downstream neurotransmitters CGRP and SP was observed in the diabetic hearts. Adenovirus-mediated NGF overexpression reversed the reduction in TRPV1 and downstream neuropeptides, resulting in improved cardiac recovery post-I/R injury in diabetic hearts. The protective effect of NGF was abolished by CGRP8-37 (a selective CGRP antagonist), while it was preserved by low-dose capsaicin.
  
  
  CONCLUSIONS
  The NGF-induced up-regulation of TRPV1 via the increased synthesis and release of endogenous CGRP leads to improved cardiac performance in I/R-injured diabetic heart.
authors: Department of Cardiovascular Sciences, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
authors: Liang-Rong
authors: LR
authors: Zheng
authors: Department of Cardiovascular Sciences, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
authors: Yuan-Yuan
authors: YY
authors: Zhang
authors: Department of Cardiovascular Sciences, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
authors: Jie
authors: J
authors: Han
authors: Department of Cardiovascular Sciences, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
authors: Ze-Wei
authors: ZW
authors: Sun
authors: Department of Geriatrics, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
authors: Shi-Xian
authors: SX
authors: Zhou
authors: Department of Cardiovascular Sciences, First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310003, China.
authors: Wen-Ting
authors: WT
authors: Zhao
authors: Department of Cardiovascular Sciences, Zhejiang Provincial People's Hospital, Hangzhou 310014, China. Electronic address: wlhhz@hotmail.com.
authors: Li-Hong
authors: LH
authors: Wang
mesh_terms: D000818:Animals; D015740:Calcitonin Gene-Related Peptide / Q000235:genetics / Q000378:metabolism; D003921:Diabetes Mellitus, Experimental / Q000150:complications / Q000235:genetics* / Q000503:physiopathology; D058065:Diabetic Cardiomyopathies / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology / Q000534:rehabilitation; D006321:Heart / Q000503:physiopathology*; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D008822:Mice, Transgenic; D017202:Myocardial Ischemia / Q000235:genetics* / Q000378:metabolism / Q000534:rehabilitation; D015428:Myocardial Reperfusion Injury / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology / Q000534:rehabilitation; D020932:Nerve Growth Factor / Q000235:genetics / Q000502:physiology*; D015398:Signal Transduction / Q000235:genetics; D013311:Streptozocin; D050916:TRPV Cation Channels / Q000235:genetics* / Q000378:metabolism; D015854:Up-Regulation / Q000235:genetics
chemical_list: D050916:TRPV Cation Channels; C493921:TRPV1 protein, mouse; D013311:Streptozocin; D020932:Nerve Growth Factor; D015740:Calcitonin Gene-Related Peptide
keywords: Heart disease; Mouse; Nerve growth factor; Reperfusion injury; TRPV1 protein; Type 2 diabetes mellitus